Experimental methods and transport models for drug delivery across the blood-brain barrier

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1346-1359

  Fu, Bingmei M ^a  

^a City College of New York   (United States)

Author keywords

Drug delivery; In vivo and in vitro blood brain barrier models; Paracellular pathway; Permeability of the bloodbrain barrier; Transcellualr pathway; Transport models

Indexed keywords

DRUG CARRIER; ION; WATER;

BLOOD BRAIN BARRIER; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DIFFUSION; DRUG DELIVERY SYSTEM; EX VIVO STUDY; EXPERIMENTAL STUDY; HUMAN; IN VIVO STUDY; LIPOPHILICITY; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; MICRODIALYSIS; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRIENT; POSITRON EMISSION TOMOGRAPHY; REVIEW; SIGNAL TRANSDUCTION; SOLUTE; TRANSCYTOSIS;

EID: 84861133148     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624409     Document Type: Review

References (126)

1. Abbott, N.J. Comparative physiology of the blood-brain barrier. In: Physiology and Pharmacology of the Blood-Brain Barrier; Bradbury, M.W.B., Ed.; Springer-Verlag: Heidelberg, 1992; pp371-396.
2. Pardridge, W. M. CNS drug design based on principles of bloodbrain barrier transport. J. Neurochem., 1998, 70, 1781-1792.
3. Abbott, N.J. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurosci. Int., 2004, 45(4), 545-555.
4. Brown, P.D.; Davies, S.L.; Speake, T.; Millar, I.D. Molecular mechanisms of cerebrospinal fluid production. Neurosci., 2004, 129(4), 957-970.
5. Pardridge, W.M. Ed. Introduction to the Blood-Brain Barrier: Methodology, biology and Pathology; Cambridge University Press: Cambridge, 2006.
6. Pardridge, W.M. Drug targeting to the brain. Pharm. Res., 2007, 24(9), 1733-1744.
7. Nag, S.; Begley, D.J. Blood-brain barrier, exchange of metabolites and gases. In: Pathology and Genetics. Cerebrovascular Diseases; ISN Neuropath. Press: Basel, 2005; pp 22-29.
8. Culter, R.W.; Page, L.; Galicich, J.; Watters, G.V. Formation and absorption of cerebrospinal fluid in man. Brain, 1968, 91(4),707-720.
9. Redzic, Z.B.; Segal, M.B. The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv. Drug Deliv. Rev., 2004, 56(12), 1695-716.
10. Smith, Q.R. Transport of glutamate and other amino acids at the blood-brain barrier. J. Nutr., 2000, 130 (4S Suppl), 1016S-1022S.
11. Zhang, Y; Pardridge, W.M. Rapid transferrin efflux from brain to blood across the blood-brain barrier. J. Neurochem., 2001, 76,1597-1600.
12. Lewandowsky, M. Zur lehre von der cerebrospinalflussigkeit. Z Klin Med., 1900, 40, 480-494.
13. Ehrlich, P. Das sauerstufbudurfnis des organismus. Hirschwald: Berlin, 1885.
14. Goldmann, E. Vitalfarbung am zentralnervensystem. Abh. K. Preuss. Akad. Wiss. Phys. Med., 1913, 1, 1-60.
15. Reese, T.S.; Karnovsky, M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol., 1967, 34(1), 207-217.
16. Adamson, R.H.; Clough, G. Plasma proteins modify the endothelial cell glycocalyx of frog mesenteric microvessels. J. Physiol., 1992, 445, 473-486.
17. Squire, J.M.; Chew, M.; Nneji, G.; Neal, C.; Barry, J.; Michel, C.C. Quasi-periodic substructure in the microvessel endothelial glycocalyx: A possible explanation for molecular filtering? J. Struct. Biol., 2001, 136(3), 239-255.
18. Ueno, M.; Sakamoto, H.; Liao, Y.J.; Onodera, M.; Huang, C.L.; Miyanaka, H.; Nakagawa. T. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem. Cell Biol., 2004, 122(2), 131-137.
19. Vink, H.; Duling, B.R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res., 1996, 79(3), 581-589.
20. Henry, C.B.; Duling, B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol., 1999, 277(2), H508-314.
21. Tarbell, J.M.; Pahakis, M.Y. Mechanotransduction and the glycocalyx. J. Int. Med., 2006, 259(4), 339-350.
22. Farkas, E.; Luiten, P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol., 2001, 64(6), 575-611.
23. Oldendorf, W.H.; Cornford, M.E.; Brown, W.J. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol., 1977, 1(5), 409-417.
24. Butt, A.M.; Jones, H.C.; Abbott, N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol., 1990, 429, 47-62.
25. Hawkins, B.T.; Davis, T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev., 2005, 57(2), 173-185.
26. Simard, M.; Arcuino, G.; Takano, T.; Liu, Q.S.; Nedergaard, M. Signaling at the gliovascular interface. J. Neurosci., 2003, 23(27), 9254-9262.
27. Kim, J.H.; Park, J.A.; Lee, S.W.; Kim, W.J.; Yu, Y.S.; Kim, K.W. Blood-neural barrier: Intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol., 2006, 39(4), 339-345.
28. Abbott, N.J.; Patabendige, A.K.; Dolman, D.E.; Yusof, S.R.; Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis., 2010, 37, 13-25.
29. Romero, I.A.; Radewicz, K.; Jubin, E.; Michel, C.C.; Greenwood, J.; Couraud, P.O.; Adamson, P. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci. Let., 2003, 344(2), 112-116.
30. Ballabh, P.; Braun, A.; Nedergaard, M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis., 2004, 16(1), 1-13.
31. Hynes, R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 1992, 69(1), 11-25.
32. Moody, D.M. The blood-brain barrier and blood-cerebral spinal fluid barrier. Semin. Cardiothorac Vasc. Anesth., 2006, 10(2), 128-131.
33. Neuwelt, E. A. Mechanisms of disease: the blood-brain barrier. Neurosurg., 2004, 54(1), 131-142.
34. Sawchuk, R.J.; Elmquist, W.F. Microdialysis in the study of drug transporters in the CNS. Adv. Drug Deliv. Rev., 2000, 45, 295-307.
35. Kay, G.G. The effects of antihistamines on cognition and performance. J. Allergy Clin. Immunol., 2000, 105(6, Pt2), S622-657.
36. Schuetz, E.G.; Schinkel, A.H.; Relling, M.V.; Schuetz, J.D. Pglycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc. Natl. Acad. Sci. USA, 1996, 93(9), 4001-4005.
37. Begley, D.J. In: Structure and Function of the Blood-Brain Barrier. Enhancement Drug Delivery. Touitou, E; Barry, B., Eds; CRC Press: Boca Raton, 2007; pp571-690.
38. Shimizu, S. A novel approach to the diagnosis and management of meralgia paresthetica. Neurosurgery, 2008, 63(4), E820.
39. Wolburg-Buchholz, K.; Mack, A.F.; Steiner, E.; Pfeiffer, F.; Engelhardt, B.; Wolburg, H. Loss of astrocyte polarity marks bloodbrain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol., 2009, 18(2), 219-233.
40. Li, G.; Yuan, W.; Fu, B.M. A model for water and solute transport across the blood-brain barrier. J. Biomech., 2010, 43(11), 2133-2140.
41. Curry, F.E. Mechanics and thermodynamics of transcapillary exchange. In: Handbook of Physiology. The cardiovascular system. American Physiology Society: Bethesda, 1984, sect.2 Vol. IV, Pt.1, Chapt. 8, pp309-374.
42. Cornford, E.M.; Young, D.; Paxton, J.W.; Sofia, R.D. Blood-brain barrier penetration of felbamate. Epilepsia., 1992, 33, 944-954.
43. van Uitert, R.L.; Sage, J.I.; Levy, D.E.; Duffy, T.E. Comparison of radio-labeled butanol and iodoantipyrine as cerebral blood flow markers. Brain Res., 1981, 222(2), 365-372.
44. Zlokovic, B.V.; Begley, D.J.; Djuricic, B.M.; Mitrovic, D.M. Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: method and application to N-methyl-alphaaminoisobutyric acid. J. Neurochem., 1986, 46(5), 1444-1451.
45. de Lange, E.C.; de Boer, B.A.; Breimer, D.D. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug Deliv. Rev., 1999, 36(2-3), 211-227.
46. Elsinga, P.H.; Hendrikse, N.H.; Bart, J.; Vaalburg, W.; van Waarde, A. PET Studies on P-glycoprotein function in the bloodbrain barrier: how it affects uptake and binding of drugs within the CNS. Curr. Pharm. Des., 2004, 10(13), 1493-1503.
47. Wang, R.; Ashwal, S.; Tone, B.; Tian, H.R.; Badaut, J.; Rasmussen, A.; Obenaus, A. Albumin reduces blood-brain barrier permeability but does not alter infarct size in a rat model of neonatal stroke. Pediatr. Res., 2007, 62(3), 261-266.
48. Gaber, M.W.; Yuan, H.; Killmar, J.T.; Naimark, M.D.; Kiani, M.F.; Merchant, T.E. An intravital microscopy study of radiationinduced changes in permeability and leukocyte-endothelial cell interactions in the microvessels of the rat pia mater and cremaster muscle. Brain Res. Protocol., 2004, 13(1), 1-10.
49. Easton, A.S.; Fraser, P.A. Variable restriction of albumin diffusion across inflamed cerebral microvessels of the anaesthetized rat. J. Physiol., 1994, 475(1), 147-157.
50. Yuan, W.; Lv, Y.; Zeng, M.; Fu, B.M. Non-invasive measurement of solute permeability in cerebral microvessels of the rat. Microvasc. Res., 2009, 77(2), 166-173.
51. Nicolazzo, J.A.; Charman, S.A.; Charman, W.N. Methods to assess drug permeability across the blood-brain barrier. J. Pharm. Pharmacol., 2006, 58(3), 281-293.
52. Allt, G.; Lawrenson, J.G. Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Rev., 1997, 24(1), 67-76.
53. Easton, A.S.; Sarker, M.H.; Fraser, P.A. Two components of bloodbrain barrier disruption in the rat. J. Physiol., 1997, 503 (3), 613-623.
54. Fu, B.M.; Shen, S. Acute VEGF effect on solute permeability of mammalian microvessels in vivo. Microvasc. Res., 2004, 68 (1), 51-62.
55. Franke, H.; Galla, H.J.; Beuckmann, C.T. An improved lowpermeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res., 1999, 818(1), 65-71.
56. Meyer, J.; Mischeck, U.; Veyhl, M.; Henzel, K.; Galla, H.J. Bloodbrain barrier characteristic enzymatic properties in cultured brain capillary endothelial cells. Brain Res., 1990, 514(2), 305-309.
57. Hemmila, J.M.; Drewes, L.R. Glucose transporter (GLUT1) expression by canine brain microvessel endothelial cells in culture: an immunocytochemical study. Adv. Exp. Med. Biol., 1993, 331, 13-18.
58. Abbott, N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat., 2002, 200(6), 629-638.
59. Haseloff, R.F.; Blasig, I.E.; Bauer, H.C.; Bauer, H. In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol. Neurobiol., 2005, 25(1), 25-39.
60. Gaillard, P.J.; de Boer, A.G. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur. J. Pharm. Sci., 2000, 12(2), 95-102.
61. Demeuse, P.; Kerkhofs, A.; Struys-Ponsar, C.; Knoops, B.; Remacle, C.; de Aguilar, P.V. Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood-brain barrier. J. Neurosci. Methods., 2002, 121(1), 21-31.
62. Deli, M.A.; Abraham, C.S.; Kataoka, Y.; Niwa, M. Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology. Cel. Mol. Neurobiol., 2005, 25(1), 59-127.
63. Brown, R.C.; Morris, A.P.; O'Neil, R.G. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res., 2007, 1130(1), 17-30.
64. Soga, N.; Connolly, J.O.; Chellaiah, M.; Kawamura, J.; Hruska, K.A. Rac regulates vascular endothelial growth factor stimulated motility. Cell Commun. Adhes., 2001, 8(1), 1-13.
65. Yoder, E.J. Modifications in astrocyte morphology and calcium signaling induced by a brain capillary endothelial cell line. Glia, 2002, 38(2), 137-145.
66. Yuan, W.; Li, G.; Fu, B.M. Effect of Surface Charge of Immortalized Mouse Cerebral Endothelial Cell Monolayer on Transport of Charged Solutes. Ann. Biomed. Eng., 2010, 38(4), 1463-1472.
67. Tyagi, N.; Moshal, K.S.; Sen, U.; Vacek, T.P.; Kumar, M.; Hughes, W.M. Jr.; Kundu, S.; Tyagi, S.C. H2S protects against methionineinduced oxidative stress in brain endothelial cells. Antioxid Redox Signal, 2009, 11(1), 25-33.
68. Omidi, Y.; Campbell, L.; Barar, J.; Connell, D.; Akhtar, S.; Gumbleton, M. Evaluation of the immortalised mouse brain capillary endothelial cell line, bEnd3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res., 2003, 990(1-2), 95-112.
69. Malina, K.C.; Cooper, I.; Teichberg, V.I. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res., 2009, 1284, 12-21.
70. Bowman, P.D.; Ennis, S.R.; Rarey, K.E.; Betz, A.L.; Goldstein, G.W. Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol., 1983, 14(4), 396-402.
71. Thompson, S.E.; Cavitt, J.; Audus, K.L. Leucine-enkephalin effects on paracellular and transcellular permeation pathways across brain microvessel endothelial-cell monolayers. J. Cardiovasc. Pharmacol., 1994, 24(5), 818-825.
72. Salvetti, F.; Cecchetti, P.; Janigro, D.; Lucacchini, A.; Benzi, L.; Martini, C. Insulin permeability across an in vitro dynamic model of endothelium. Pharm. Res., 2002, 19(4), 445-450.
73. Karyekar, C.S.; Fasano, A.; Raje, S.; Lu, R.L.; Dowling, T.C.; Eddington, N.D. Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. J. Pharm. Sci., 2003, 92(2), 414-423.
74. Hamm, S.; Dehouck, B.; Kraus, J.; Wolburg-Buchholz, K.; Wolburg, H.; Risau, W.; Cecchelli, R.; Engelhardt, B.; Dehouck, M.P. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res., 2004, 315(2), 157-166.
75. Kemper, E.M.; Boogerd, W.; Thuis, I.; Beijnen, J.H.; van Tellingen, O. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treat. Rev., 2004, 30(5), 415-423.
76. Boveri, M.; Berezowski, V.; Price, A.; Slupek, S.; Lenfant, A.M.; Benaud, C.; Hartung, T.; Cecchelli, R.; Prieto, P.; Dehouck, M.P. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: Comparison between primary glial cells and C6 cell line. Glia, 2005, 51(3), 187-198.
77. Kraus, J.; Voigt, K.; Schuller, A.M.; Scholz, M.; Kim, K.S.; Schilling, M.; Schabitz, W.R.; Oschmann, P.; Engelhardt, B. Interferonbeta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro. Mult. Scler., 2008, 14(6), 843-852.
78. Poller, B.; Gutmann, H.; Krahenbuhl, S.; Weksler, B.; Romero, I.; Couraud, P.O.; Tuffin, G.; Drewe, J.; Huwyler, J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J. Neurochem., 2008, 107(5), 1358-1368.
79. Sahagun, G.; Moore, S.A.; Hart, M.N. Permeability of neutral vs. anionic dextrans in cultured brain microvascular endothelium. Am. J. Physiol., 1990, 259(1 Pt 2), H162-166.
80. Santaguida, S.; Janigro, D.; Hossain, M.; Oby, E.; Rapp, E.; Cucullo, L. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: A permeability study. Brain Res., 2006, 1109(1), 1-13.
81. de Vries, H.E.; BlomRoosemalen, M.C.M.; van Oosten, M.; de Boer, A.G.; van Berkel, T.J.; Breimer, D.D.; Kuiper, J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol., 1996, 64(1), 37-43.
82. Cucullo, L.; McAllister, M.S.; Kight, K.; Krizanac-Bengez, L.; Marroni, M.; Mayberg, M.R.; Stanness, K. A.; Janigro, D. A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res., 2002, 951(2), 243-254.
83. Zhang, Y.; Li, C.S.; Ye, Y.Y.; Johnson, K.; Poe, J.; Johnson, S.; Bobrowski, W.; Garrido, R.; Madhu, C. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab. Dispos., 2006, 34(11), 1935-1943.
84. Li, G.; Simon, M.; Shi, Z.; Cancel, L.; Tarbell, J.M.; Morrison, B.; Fu, B.M. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery. Ann. Biomed. Eng., 2010, 38(8), 2499-2511.
85. Engvall, E. Structure and function of basement membranes. Int. J. Dev. Biol., 1995, 39(5), 781-787.
86. Miosge, N. The ultrastructural composition of basement membranes in vivo. Histol. Histopathol., 2001, 16(4), 1239-1248.
87. Kleinman, H.K.; Martin, G.R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol., 2005, 15(5), 378-386.
88. Pardridge, W.M. Molecular biology of the blood-brain barrier. Methods Mol. Biotech., 2003, 89, 385-399.
89. Dietrich, W.D.; Alonso, O.; Halley, M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J. Neurotrauma, 1994, 11(3), 289-301.
90. Fukuda, K.; Tanno, H.; Okimura, Y.; Nakamura, M.; Yamaura, A. The blood-brain barrier disruption to circulating proteins in the early period after fluid percussion brain injury in rats. J. Neurotrauma, 1995, 12(3), 315-324.
91. Baldwin, S.A.; Fugaccia, I.; Brown, D.R.; Brown, L.V.; Scheff, S.W. Blood-brain barrier breach following cortical contusion in the rat. J. Neurosurg., 1996, 85(3), 476-481.
92. Barzo, P.; Marmarou, A.; Fatouros, P.; Corwin, F.; Dunbar, J. Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J. Neurosurg., 1996, 85(6), 1113-1121.
93. Baskaya, M.K.; Rao, A.M.; Dogan, A.; Donaldson, D.; Dempsey, R.J. The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci. Lett., 1997, 226(1), 33-36.
94. Beaumont, A.; Marmarou, A.; Hayasaki, K.; Barzo, P.; Fatouros, P.; Corwin, F.; Marmarou, C.; Dunbar, J. The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir. Suppl., 2000, 76, 125-129.
95. Cernak, I.; Vink, R.; Zapple, D.N.; Cruz, M.I.; Ahmed, F.; Chang, T.; Fricke, S.T.; Faden, A.I. The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol. Dis., 2004, 17(1), 29-43.
96. Fu, B.M.; Chen, B. A model for the structural mechanisms in the regulation of microvessel permeability by junction strands. ASME J. Biomech. Eng., 2003, 125(5), 620-627.
97. Fu, B.M.; Tsay, R.; Curry, F.E.; Weinbaum. S. A junction-orificeentrance layer model for capillary permeability: Application to frog mesenteric capillaries. ASME J. Biomech. Eng., 1994, 116(4), 502-513.
98. Schulze, C.; Firth, J.A. Interendothelial junctions during bloodbrain-barrier development in the rat-morphological-changes at the level of individual tight junctional contacts. Dev. Brain Res., 1992, 69(1), 85-95.
99. Adamson, R.H.; Lenz, J.E.; Zhang, X.; Adamson, G.N.; Weinbaum, S.; Curry, F.E. Oncotic pressures opposing filtration across nonfenestrated rat microvessels. J. Physiol., 2004, 557(Pt3), 889-907.
100. Li, G.; Fu, B.M. An Electro-diffusion Model for the Blood-Brain Barrier Permeability to Charged Molecule. ASME J. Biomech. Eng., 2011, 133(2), 021002.
101. Mak, M.; Fung, L.; Strasser, J.F.; Saltzman, W.M. Distribution of drugs following controlled delivery to the brain interstitium. J. Neurooncol., 1995, 26(2), 91-102.
102. Bobo, R.H.; Laske, D.W.; Akbasak, A.; Morrison, P.F.; Dedrick, R.L.; Oldfield, E.H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA, 1994, 91(6), 2076-2080.
103. Kroll, R.A.; Neuwelt, E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery., 1998, 42(5),1083-1099.
104. Doolittle, N.D.; Abrey, L.E.; Ferrari, N.; Hall, W.A.; Laws, E.R.; McLendon, R.E.; Muldoon, L.L.; Peereboom, D.; Peterson, D.R.; Reynolds, C.P.; Senter, P.; Neuwelt, E.A. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the blood-brain barrier disruption consortium. Clin. Cancer Res., 2002, 8(6), 1702-1709.
105. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Jolesz, F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology, 2001, 220(3), 640-646.
106. Hynynen, K.; McDannold, N.; Vykhodtseva, N.; Raymond, S.; Weissleder, R.; Jolesz, F.A.; Sheikov, N. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J. Neurosurg., 2006, 105(3), 445-454.
107. Kinoshita, M. Targeted drug delivery to the brain using focused ultrasound. Top. Magn. Reson Imaging, 2006, 17(3), 209-215.
108. Dean, R.L.; Emerich, D.F.; Hasler, B.P.; Bartus, R.T. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone. Neuro. Oncol., 1999, 1(4), 268.
109. Borlongan, C.V.; Emerich, D.F. Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist. Cereport. Brain Res. Bull., 2003, 60(3), 297-306.
110. Gabathuler, R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol. Dis., 2010, 37(1), 48-57.
111. Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods, 2000, 44(1), 235-249.
112. Shashoua, V.E.; Hesse, G.W. N-docosahexaenoyl, 3 hydroxytyramine: a dopaminergic compound that penetrates the blood-brain barrier and suppresses appetite. Life Sci. 1996, 58(16), 1347-1357.
113. Sawada, G.A.; Williams, L.R.; Lutzke, B.S., Raub, T.J. Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites. J. Pharmacol. Exp. Ther., 1999, 288(3), 1327-1333.
114. Bodor, N.; Farag, H.H.; Brewster, M.E. Site-specific, sustained release of drugs to the brain. Science, 1981, 214(4527), 1370-1372.
115. Brewster, M.E.; Raghavan, K.; Pop, E.; Bodor, N. Enhanced delivery of ganciclovir to the brain through the use of redox targeting. Antimicrob. Agents Chemother., 1994, 38(4), 817-823.
116. Pardridge, W.M. Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv., 2003, 3(2), 90-105.
117. Pardridge, W.M. Molecular Trojan horses for blood-brain barrier drug delivery. Curr. Opin. in Pharm., 2006, 6(5), 494-500.
118. Miller, G. Drug targeting. Breaking down barriers. Science, 2002, 297(5584), 1116-1118.
119. Gosk, S.; Vermehren, C.; Storm, G.; Moos, T. Targeting antitransferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J. Cereb. Blood Flow Metab., 2004, 24(11), 1193-1204.
120. Kumagai, A.K.; Eisenberg, J.B.; Pardridge, W.M. Absorptivemediated endocytosis of cationized albumin and a beta-endorphincationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem., 1987, 262(31), 15214-15219.
121. Lawrenson, J. G.; Reid, A. R.; Allt, G. Molecular characteristics of pial microvessels of the rat optic nerve. Can pial microvessels be used as a model for the blood-brain barrier? Cell Tissue Res., 1997, 288, 259-265.
122. Yuan, W.; Li, G.; Zeng, M.; Fu, B.M. Modulation of the Bloodbrain barrier permeability by plasma glycoprotein orosomucoid. Microvasc. Res., 2010, 80(1), 148-157.
123. Hervé, F.; Ghinea, N.; Scherrmann, J.M. CNS delivery via adsorptive transcytosis. AAPS J., 2008, 10(3), 455-472.
124. Rousselle, C.; Clair, P.; Smirnova, M.; Kolesnikov, Y.; Pasternak, G.W.; Gac-Breton, S.; Rees, A.R.; Scherrmann, J.M.; Temsamani, J. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. J. Pharmacol. Exp. Ther., 2003, 306(1), 371-376.
125. Liu, L.; Guo, K.; Lu, J.; Venkatraman, S.S.; Luo, D.; Ng, K.C.; Ling, E.A.; Moochhala, S.; Yang, Y.Y. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials, 2008, 29(10),1509-1517.
126. Lockman, P.R.; Koziara, J.M.; Mumper, R.J.; Allen, D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target, 2004, 12(9-10), 635-641.